| Literature DB >> 15657632 |
B Goffe1.
Abstract
Etanercept is a tumor necrosis factor antagonist with anti-inflammatory effects. It is currently approved in the US for psoriasis, psoriatic arthritis, ankylosing spondylitis, rheumatoid arthritis and juvenile rheumatoid arthritis. Clinical trials have shown this agent to have an excellent safety profile and to be well tolerated by both adult and pediatric patients.Entities:
Mesh:
Substances:
Year: 2004 PMID: 15657632
Source DB: PubMed Journal: Skin Therapy Lett ISSN: 1201-5989